The MITF regulatory network in melanoma

Area of Science:

• Oncology
• Cancer Biology
• Immunology

Background:

• Tumor cells interact with their microenvironment, influencing evolution and metastasis through phenotypic plasticity.
• The microphthalmia-associated transcription factor (MITF) is crucial in melanoma, regulating proliferation, senescence, immune infiltration, and therapy resistance.
• Mechanisms by which MITF regulates gene expression and impacts immune infiltration in melanoma are not fully understood.

Purpose of the Study:

• To elucidate the mechanisms of MITF-regulated gene expression in melanoma.
• To identify factors interacting with MITF.
• To understand how MITF and associated signaling pathways influence immune infiltration in melanoma.

Main Methods:

• Analysis of MITF binding sites and associated DNA motifs.
• Identification of MITF-interacting proteins using proteomic approaches.
• Correlation of MITF expression, AP1 activity, β-catenin signaling, Notch signaling, and immune infiltration in melanoma models and human samples.

Main Results:

• MITF binds to E/M-box motifs for gene activation and to FOS/JUN/AP1/ATF3 sites for gene repression.
• JUN and ATF3 were identified as novel MITF interactors.
• High AP1 activity correlates with MITF-low, invasive melanoma phenotypes.
• Low MITF, in conjunction with Notch signaling, is associated with increased immune infiltration in both mouse and human melanoma.

Conclusions:

• MITF represses AP1-regulated genes, contributing to a pro-proliferative phenotype in melanoma.
• MITF's interaction with JUN and ATF3 provides new insights into melanoma cell plasticity.
• Low MITF combined with Notch signaling promotes immune infiltration, offering potential therapeutic strategies for melanoma.